Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004863925 | SCV005496772 | uncertain significance | not specified | 2024-08-04 | criteria provided, single submitter | clinical testing | The c.490G>A (p.E164K) alteration is located in exon 2 (coding exon 2) of the SEMG1 gene. This alteration results from a G to A substitution at nucleotide position 490, causing the glutamic acid (E) at amino acid position 164 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |